| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. |
BXDS-WLE |
Peer-Reviewed Article |
Health |